ProfileGDS4718 / 222427_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 87% 85% 93% 86% 86% 93% 95% 88% 86% 87% 89% 80% 90% 92% 90% 91% 90% 92% 92% 88% 88% 88% 88% 89% 86% 92% 86% 92% 88% 94% 93% 93% 83% 85% 97% 95% 91% 88% 88% 95% 89% 93% 92% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.7290387
GSM549102patient 115, normal, homogenized [OPG study]8.4343485
GSM549104patient 119, normal, homogenized [OPG study]9.8018593
GSM549108patient 138, normal, homogenized [OPG study]8.5531486
GSM549119patient 077, normal, homogenized [OPG study]8.6109286
GSM549133patient 032, cancer, homogenized [OPG study]9.7505693
GSM549139patient 042, cancer, homogenized [OPG study]10.311595
GSM549099patient 107, normal, homogenized [OPG study]8.7656688
GSM549109patient 139, normal, homogenized [OPG study]8.6086286
GSM549110patient 046, normal, homogenized [OPG study]8.7052487
GSM549114patient 063, normal, homogenized [OPG study]9.2098689
GSM549122patient 082, normal, homogenized [OPG study]7.8719180
GSM549134patient 033, cancer, homogenized [OPG study]9.2400190
GSM549136patient 036, cancer, homogenized [OPG study]9.682792
GSM549140patient 044, cancer, homogenized [OPG study]9.3056690
GSM549111patient 047, normal, homogenized [OPG study]9.389791
GSM549113patient 057, normal, homogenized [OPG study]9.3568290
GSM549132patient 031, cancer, homogenized [OPG study]9.4419192
GSM549137patient 038, cancer, homogenized [OPG study]9.5355592
GSM549142patient 047, cancer, homogenized [OPG study]8.4080488
GSM549100patient 110, normal, homogenized [OPG study]8.7917188
GSM549107patient 135, normal, homogenized [OPG study]8.8708988
GSM549115patient 068, normal, homogenized [OPG study]8.991288
GSM549116patient 072, normal, homogenized [OPG study]9.2004489
GSM549120patient 078, normal, homogenized [OPG study]8.5607986
GSM549131patient 030, cancer, homogenized [OPG study]9.609792
GSM549118patient 074, normal, homogenized [OPG study]8.6104586
GSM549129patient 027, cancer, homogenized [OPG study]9.3975892
GSM549123patient 088, normal, homogenized [OPG study]8.9268888
GSM549124patient 006, cancer, homogenized [OPG study]9.9029894
GSM549126patient 015, cancer, homogenized [OPG study]9.5777693
GSM549128patient 025, cancer, homogenized [OPG study]9.7836493
GSM549103patient 117, normal, homogenized [OPG study]8.1054983
GSM549117patient 073, normal, homogenized [OPG study]8.6391385
GSM549138patient 041, cancer, homogenized [OPG study]10.707597
GSM549141patient 045, cancer, homogenized [OPG study]10.27395
GSM549130patient 028, cancer, homogenized [OPG study]9.2730291
GSM549101patient 111, normal, homogenized [OPG study]8.8142488
GSM549105patient 128, normal, homogenized [OPG study]8.8128188
GSM549106patient 134, normal, homogenized [OPG study]10.283295
GSM549112patient 048, normal, homogenized [OPG study]9.1103289
GSM549125patient 011, cancer, homogenized [OPG study]9.65693
GSM549127patient 024, cancer, homogenized [OPG study]9.5252692
GSM549135patient 035, cancer, homogenized [OPG study]10.150295